AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14681620 — intervention group
Group type: EXPERIMENTAL
Intervention: External jugular vein (EJV) patch
Number of subjects: 160
Study 14681620 — intervention group
Group type: COMPARATOR
Intervention: Polytetrafluoroethylene (PTFE) patch
Number of subjects: 160
Study 11404143 — intervention group
Group type: EXPERIMENTAL
Intervention: hFABP
Number of subjects: 35
Study 11404143 — intervention group
Group type: EXPERIMENTAL
Intervention: CKMB
Number of subjects: 35
Study 11404143 — intervention group
Group type: EXPERIMENTAL
Intervention: TnI
Number of subjects: 35
Study 9241289 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model using maternal age, height, weight at delivery, nulliparity, history of cesarean delivery, and need for induction of labor.
Number of subjects: 0
Study 9241289 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model with additional variable of need for labor augmentation.
Number of subjects: 0
Study 8304709 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant interleukin‐2 (rIL‐2)
Number of subjects: 12
Study 3584272 — intervention group
Group type: EXPERIMENTAL
Intervention: Oros drug delivery system (10/170 oxprenolol)
Number of subjects: 8
Study 3584272 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral solution
Number of subjects: 8
Study 3584272 — intervention group
Group type: COMPARATOR
Intervention: Slow Trasicor 160 mg orally
Number of subjects: 8
Study 3584272 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal administration of pre‐equilibrated Oros systems
Number of subjects: 8
Study 30807594 — intervention group
Group type: EXPERIMENTAL
Intervention: AAQ II Malay version
Number of subjects: 101
Study 30807594 — intervention group
Group type: COMPARATOR
Intervention: Non-cancer patients
Number of subjects: 101
Study 27910245 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid-state sensors in seated position
Number of subjects: 78
Study 27910245 — intervention group
Group type: COMPARATOR
Intervention: Solid-state sensors in lateral position
Number of subjects: 78
Study 27910245 — intervention group
Group type: COMPARATOR
Intervention: Water-perfused sensors in lateral position
Number of subjects: 78
Study 25430065 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrinsic cognitive load manipulation (varying number of diagnoses learned in one instruction session)
Number of subjects: 0
Study 25430065 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraneous cognitive load manipulation (providing single or multiple examples of diagnoses during instruction)
Number of subjects: 0
Study 25430065 — intervention group
Group type: EXPERIMENTAL
Intervention: Germane cognitive load manipulation (employing mixed or blocked sequences of diagnostic examples)
Number of subjects: 0
Study 23591255 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous-combined estradiol 1 mg/drospirenone 2 mg (E2D)
Number of subjects: 23
Study 23591255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 21990176 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen 10 mg, 3 times per day, orally
Number of subjects: 44
Study 21990176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 18496952 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency bypass during clipping procedure (group I)
Number of subjects: 46
Study 18496952 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency bypass for therapy refractory vasospasm (group II)
Number of subjects: 46
Study 18496952 — intervention group
Group type: COMPARATOR
Intervention: Planned bypass surgery (group III)
Number of subjects: 46
Study 16803941 — intervention group
Group type: EXPERIMENTAL
Intervention: Examination without stirrups
Number of subjects: 197
Study 16803941 — intervention group
Group type: COMPARATOR
Intervention: Examination with stirrups
Number of subjects: 197
Study 12652173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone loading for 24 hours
Number of subjects: 45
Study 12652173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 10912543 — intervention group
Group type: EXPERIMENTAL
Intervention: Deflazacort (0.30+/‐0.03 mg/kg per day)
Number of subjects: 27
Study 10912543 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisone (0.20+/‐0.03)
Number of subjects: 27
Study 10912543 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisone
Number of subjects: 27
Study 10912543 — intervention group
Group type: EXPERIMENTAL
Intervention: Deflazacort
Number of subjects: 27
Study 10912543 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 27
Study 8793024 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 10
Study 8793024 — intervention group
Group type: COMPARATOR
Intervention: Concentric exercise
Number of subjects: 10
Study 1643923 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled furosemide (20 mg)
Number of subjects: 6
Study 1643923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 6228459 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 micrograms heat-inactivated HBsAg vaccine
Number of subjects: 698
Study 6228459 — intervention group
Group type: EXPERIMENTAL
Intervention: 27 micrograms heat-inactivated HBsAg vaccine
Number of subjects: 698
Study 31866529 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased frequency of sensor use
Number of subjects: 0
Study 31866529 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive Low Glucose Management (PLGM) system
Number of subjects: 0
Study 31866529 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger children
Number of subjects: 0
Study 31376515 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisia afra extracts and compounds
Number of subjects: 0
Study 31376515 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised controlled trials (RCTs)
Number of subjects: 0
Study 27888737 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyadic sibling-focused intervention
Number of subjects: 328
Study 26332605 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC01 intravenous (i.v.) infusion at 20 mg/kg
Number of subjects: 28
Study 26332605 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC01 intravenous (i.v.) infusion at 40 mg/kg
Number of subjects: 28
Study 26332605 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC01 subcutaneous (s.c.) delivery at 5 mg/kg
Number of subjects: 28
Study 26332605 — intervention group
Group type: COMPARATOR
Intervention: Placebo s.c. given twice, 28 days apart
Number of subjects: 28
Study 26332605 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC01 (all doses)
Number of subjects: 28
Study 26332605 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC01 (5-40 mg/kg i.v. range)
Number of subjects: 28
Study 26332605 — intervention group
Group type: EXPERIMENTAL
Intervention: VRC01
Number of subjects: 28
Study 22855005 — intervention group
Group type: EXPERIMENTAL
Intervention: MnCOSA
Number of subjects: 62
Study 22855005 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 62
Study 21097899 — intervention group
Group type: EXPERIMENTAL
Intervention: LVEF quartiles 23-28%
Number of subjects: 2008
Study 21097899 — intervention group
Group type: EXPERIMENTAL
Intervention: LVEF quartiles 17-22%
Number of subjects: 2008
Study 21097899 — intervention group
Group type: EXPERIMENTAL
Intervention: LVEF quartiles < 17%
Number of subjects: 2008
Study 19127261 — intervention group
Group type: EXPERIMENTAL
Intervention: WBRT+topotecan (RCT; 0.4 mg m(‐2) day(‐1) x 20)
Number of subjects: 96
Study 19127261 — intervention group
Group type: COMPARATOR
Intervention: WBRT (20 x 2 Gy)
Number of subjects: 96
Study 19127261 — intervention group
Group type: EXPERIMENTAL
Intervention: WBRT+topotecan (RCT)
Number of subjects: 96
Study 18379495 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral blockades (PVB)
Number of subjects: 67
Study 18379495 — intervention group
Group type: COMPARATOR
Intervention: Antianginal and metabolic therapy
Number of subjects: 67
Study 15475832 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g oleic capsaicin-containing patches
Number of subjects: 12
Study 15475832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 11534472 — intervention group
Group type: EXPERIMENTAL
Intervention: Western diet composed of 45% fat, 40% carbohydrate and 15% protein by energy
Number of subjects: 8
Study 11534472 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard breakfast of constant composition
Number of subjects: 8
Study 9769871 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 nucleoside analogues
Number of subjects: 30
Study 9769871 — intervention group
Group type: COMPARATOR
Intervention: 2 nucleoside analogues and a protease inhibitor
Number of subjects: 30
Study 8933253 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention provided to parents in the post-natal period.
Number of subjects: 169
Study 8933253 — intervention group
Group type: COMPARATOR
Intervention: Control group (no health education intervention).
Number of subjects: 169
Study 2390434 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg mefloquine base weekly
Number of subjects: 20
Study 2390434 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg mefloquine base weekly
Number of subjects: 20
Study 6786115 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling (N: 20)
Number of subjects: 40
Study 6786115 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic counseling (N: 20)
Number of subjects: 40
Study 6786115 — intervention group
Group type: COMPARATOR
Intervention: Control group (N: 20)
Number of subjects: 40
Study 31845008 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based educational workshop
Number of subjects: 156
Study 31268730 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual educational session with a promotora
Number of subjects: 100
Study 31268730 — intervention group
Group type: EXPERIMENTAL
Intervention: Group educational session with a promotora
Number of subjects: 100
Study 31268730 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 100
Study 27630110 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Caregivers‐Healthy Children (HC2) intervention
Number of subjects: 1211
Study 27630110 — intervention group
Group type: COMPARATOR
Intervention: Injury prevention/safety intervention (Control)
Number of subjects: 1211
Study 27258249 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg FeLf (iron-lactoferrin complex) per day
Number of subjects: 35
Study 27258249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 23791561 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck manual therapy
Number of subjects: 68
Study 23791561 — intervention group
Group type: COMPARATOR
Intervention: Pragmatic, evidence-based treatment to the shoulder (control group)
Number of subjects: 68
Study 23791561 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 68
Study 22995971 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin anticoagulation with INR of 2 to 3
Number of subjects: 4060
Study 20973464 — intervention group
Group type: EXPERIMENTAL
Intervention: Newcastle disease vaccination program for chickens
Number of subjects: 498
Study 20973464 — intervention group
Group type: COMPARATOR
Intervention: Control villages (no vaccination)
Number of subjects: 498
Study 18005833 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal anchorage (n = 10)
Number of subjects: 23
Study 18005833 — intervention group
Group type: COMPARATOR
Intervention: Orthognathic surgery (LeFort I osteotomy combined with mandibular osteotomy) (n = 13)
Number of subjects: 23
Study 18005833 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 23
Study 16047062 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening program including free and total prostate specific antigen (PSA) and digital rectal examination (DRE)
Number of subjects: 1213
Study 16047062 — intervention group
Group type: EXPERIMENTAL
Intervention: Transrectal ultrasound (TRUS) and ultrasound guided biopsy of the prostate
Number of subjects: 1213
Study 11851660 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic abdominal rectopexy
Number of subjects: 40
Study 11851660 — intervention group
Group type: COMPARATOR
Intervention: Open abdominal rectopexy
Number of subjects: 40
Study 9550207 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor exercises
Number of subjects: 60
Study 9550207 — intervention group
Group type: COMPARATOR
Intervention: Vaginal weight cones
Number of subjects: 60
Study 7874873 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose warfarin with responsive thromboplastin
Number of subjects: 0
Study 7874873 — intervention group
Group type: COMPARATOR
Intervention: High-dose warfarin with high international sensitivity index thromboplastin
Number of subjects: 0
Study 2965227 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 52
Study 2965227 — intervention group
Group type: COMPARATOR
Intervention: Methyldopa
Number of subjects: 52
Study 2965227 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics and vasodilating agents (added where blood pressure was insufficiently controlled)
Number of subjects: 52
Study 2965227 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 52
Study 2965227 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment (beta-blockers and methyldopa)
Number of subjects: 52
Study 31955619 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF‐α inhibitor (Group A)
Number of subjects: 90
Study 31955619 — intervention group
Group type: COMPARATOR
Intervention: Steroid (Group B)
Number of subjects: 90
Study 31955619 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine-only (Group C)
Number of subjects: 90
Study 30343318 — intervention group
Group type: COMPARATOR
Intervention: 2-L/kg/min high-flow nasal cannula (HFNC)
Number of subjects: 286
Study 30343318 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-L/kg/min high-flow nasal cannula (HFNC)
Number of subjects: 286
Study 26933813 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 million allo-hMSCs
Number of subjects: 45
Study 26933813 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 million allo-hMSCs
Number of subjects: 45
Study 26933813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 25490946 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based health promotion intervention
Number of subjects: 1440
Study 22951670 — intervention group
Group type: EXPERIMENTAL
Intervention: Test of Memory Malingering (TOMM) with CNS measures
Number of subjects: 311
Study 22951670 — intervention group
Group type: COMPARATOR
Intervention: Standard TOMM scores
Number of subjects: 311
Study 22951670 — intervention group
Group type: EXPERIMENTAL
Intervention: TOMM CNS scores
Number of subjects: 311
Study 20412883 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 52
Study 18663167 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 kcal/wk physical activity
Number of subjects: 201
Study 18663167 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 kcal/wk physical activity
Number of subjects: 201
Study 18663167 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity physical activity
Number of subjects: 201
Study 18663167 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous intensity physical activity
Number of subjects: 201
Study 18663167 — intervention group
Group type: EXPERIMENTAL
Intervention: Performing more physical activity (1835 kcal/wk or 275 min/wk)
Number of subjects: 201
Study 21966753 — intervention group
Group type: COMPARATOR
Intervention: Progesterone (100 mg/day IM)
Number of subjects: 69
Study 21966753 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol (2 mg of estradiol valerianate) plus progesterone (100 mg/day IM)
Number of subjects: 69
Study 21966753 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol levels on day 7 post-transfer
Number of subjects: 69
Study 21966753 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone levels on day 7 post-transfer
Number of subjects: 69
Study 21966753 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol levels predictive of pregnancy
Number of subjects: 69
Study 21966753 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone levels predictive of pregnancy
Number of subjects: 69
Study 12161047 — intervention group
Group type: EXPERIMENTAL
Intervention: Menorest 50 microg/24 h (estradiol 4.3 mg) and Gestapuran 2.5 mg (medroxyprogesteron) daily
Number of subjects: 40
Study 12161047 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 40
Study 10583115 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 p.p.m. nickel concentration in water for 10 min daily for the first week, followed by 100 p.p.m. nickel concentration for the second week
Number of subjects: 0
Study 10583115 — intervention group
Group type: COMPARATOR
Intervention: Water immersion (control group)
Number of subjects: 0
Study 8947405 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical catheter fiberoptic system
Number of subjects: 44
Study 8947405 — intervention group
Group type: COMPARATOR
Intervention: Standard rod-lens arthroscope
Number of subjects: 44
Study 1341246 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified follow-up (Group II)
Number of subjects: 106
Study 1341246 — intervention group
Group type: COMPARATOR
Intervention: Conventional follow-up (Group I)
Number of subjects: 106
Study 6393417 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 40 mg daily
Number of subjects: 21
Study 6393417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 6393417 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Prednisolone and Placebo
Number of subjects: 21
Study 6393417 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 21
Study 31536101 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg once daily (n=3023)
Number of subjects: 6042
Study 31536101 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride 1 to 4 mg once daily (n=3010)
Number of subjects: 6042
Study 30421996 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing as an immigration inspector
Number of subjects: 0
Study 30421996 — intervention group
Group type: COMPARATOR
Intervention: Playing a similar game as a newspaper editor
Number of subjects: 0
Study 26660265 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention to implement brief smoking cessation counseling based on the 5As
Number of subjects: 20
Study 26660265 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 20
Study 26660265 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 20
Study 24524204 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Sedation Interruption (DSI) in combination with protocolized sedation
Number of subjects: 0
Study 24524204 — intervention group
Group type: COMPARATOR
Intervention: Protocolized continuous sedation
Number of subjects: 0
Study 22871933 — intervention group
Group type: EXPERIMENTAL
Intervention: Zilpaterol HCl (8.33 mg/kg DM)
Number of subjects: 3382
Study 22871933 — intervention group
Group type: EXPERIMENTAL
Intervention: Zilpaterol HCl (8.33 mg/kg DM) with 148 DOF
Number of subjects: 3382
Study 20298254 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,064‐nm Q‐switched neodymium-doped yttrium aluminum garnet (QS‐Nd:YAG) laser treatment
Number of subjects: 22
Study 20298254 — intervention group
Group type: COMPARATOR
Intervention: Topical treatment (2% hydroquinone)
Number of subjects: 22
Study 17522081 — intervention group
Group type: COMPARATOR
Intervention: Group A (no observation time post-ablation)
Number of subjects: 90
Study 17522081 — intervention group
Group type: COMPARATOR
Intervention: Group B (30 min observation time post-ablation)
Number of subjects: 90
Study 17522081 — intervention group
Group type: COMPARATOR
Intervention: Group C (60 min observation time post-ablation)
Number of subjects: 90
Study 17522081 — intervention group
Group type: COMPARATOR
Intervention: Group B (30 min observation time)
Number of subjects: 90
Study 17522081 — intervention group
Group type: COMPARATOR
Intervention: Group B (60 min observation time)
Number of subjects: 90
Study 17522081 — intervention group
Group type: COMPARATOR
Intervention: Group C (30 min observation time)
Number of subjects: 90
Study 17522081 — intervention group
Group type: COMPARATOR
Intervention: Group C (60 min observation time)
Number of subjects: 90
Study 16294613 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring techniques
Number of subjects: 0
Study 16294613 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 0
Study 16294613 — intervention group
Group type: COMPARATOR
Intervention: Attentional control group
Number of subjects: 0
Study 11932276 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed (40 g daily for 3 months)
Number of subjects: 100
Study 11932276 — intervention group
Group type: COMPARATOR
Intervention: Wheat-based comparative control regimen (40 g daily for 3 months)
Number of subjects: 100
Study 11932276 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed and Wheat-based comparative control regimen
Number of subjects: 100
Study 9795409 — intervention group
Group type: EXPERIMENTAL
Intervention: BMT (bismuth subsalicylate 600 mg t. i. d. for 28 days, metronidazole 400 mg t. i. d. and tetracycline 500 mg q. i. d. for ten days)
Number of subjects: 220
Study 9795409 — intervention group
Group type: EXPERIMENTAL
Intervention: OA (omeprazole 40 mg o. d. and amoxicillin 750 mg q. i. d. for 14 days)
Number of subjects: 220
Study 9795409 — intervention group
Group type: EXPERIMENTAL
Intervention: OC (omeprazole 40 mg o. d. and clarithromycin 500 mg b. i. d. for 14 days)
Number of subjects: 220
Study 9795409 — intervention group
Group type: EXPERIMENTAL
Intervention: OT (omeprazole 40 mg o. d. and tetracycline 500 mg q. i. d. for 14 days)
Number of subjects: 220
Study 9795409 — intervention group
Group type: EXPERIMENTAL
Intervention: OMC (omeprazole 40 mg o. d., metronidazole 400 mg t. i. d. and clarithromycin 250 mg b. i. d. for seven days)
Number of subjects: 220
Study 8578768 — intervention group
Group type: EXPERIMENTAL
Intervention: DV‐7751a 100 mg
Number of subjects: 0
Study 8578768 — intervention group
Group type: EXPERIMENTAL
Intervention: DV‐7751a 200 mg
Number of subjects: 0
Study 8578768 — intervention group
Group type: EXPERIMENTAL
Intervention: DV‐7751a 400 mg
Number of subjects: 0